Hutchmed (China) (HKG:0013) has delayed the dispatch of a circular regarding the proposed disposal of a 45% stake in Shanghai Hutchison Pharmaceuticals, according to a Tuesday Hong Kong bourse filing.
The delay is due to the company requiring more time to complete certain activities under the agreement.
The parties initially entered into the contract on Dec. 31, 2024.